{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:16:01Z","timestamp":1776492961532,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ygyno.2015.12.010","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T19:04:41Z","timestamp":1450379081000},"page":"234-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer"],"prefix":"10.1016","volume":"140","author":[{"given":"Diana","family":"Cholakian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda N.","family":"Fader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola A.","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-1642","authenticated-orcid":false,"suffix":"III","given":"Edward J.","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.12.010_bb0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.gco.0000169108.15623.34","article-title":"Fertility preservation options for female patients with malignancies","volume":"17","author":"Seli","year":"2005","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0010","first-page":"699","article-title":"Endometrial carcinoma in women 40years of age or younger","volume":"57","author":"Crissman","year":"1981","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0015","first-page":"417","article-title":"Adenocarcinoma of the endometrium in women 40years of age or younger","volume":"64","author":"Gallup","year":"1984","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0020","first-page":"1","article-title":"Births: preliminary data for 2012","volume":"62","author":"Hamilton","year":"2013","journal-title":"Natl. Vital Stat. Rep."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1479-828X.2009.00981.x","article-title":"The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review","volume":"49","author":"Buttini","year":"2009","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0030","first-page":"137","article-title":"Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices","volume":"18","author":"Perino","year":"1987","journal-title":"Acta Eur. Fertil."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0035","article-title":"Megestrol acetate for treatment of anorexia\u2013cachexia syndrome","volume":"3","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0040","first-page":"284","article-title":"Levo-norgestrel-nova-T and precancerous lesions of the endometrium","volume":"9","author":"Scarselli","year":"1988","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejogrb.2008.02.022","article-title":"The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia\u2014a long-term follow-up study","volume":"139","author":"Varma","year":"2008","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2003.07.002","article-title":"Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone","volume":"91","author":"Vereide","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.maturitas.2006.12.004","article-title":"Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up","volume":"57","author":"Wildemeersch","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0070","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archpedi.160.1.40","article-title":"Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method","volume":"160","author":"Bonny","year":"2006","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008815.pub3","article-title":"Progestin-only contraceptives: effects on weight","volume":"7","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2013.03.004","article-title":"Weight change at 12months in users of three progestin-only contraceptive methods","volume":"88","author":"Vickery","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0090","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0095","article-title":"Influence of comorbidity on the risk of death: a single institution study of 1132 women with early-stage uterine cancer","author":"Elshaikh","year":"2014","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ijc.29427","article-title":"Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women","volume":"137","author":"Dougan","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0110","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/jama.2014.2269","article-title":"Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis","volume":"311","author":"Aune","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0115","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2105\/AJPH.2013.301379","article-title":"The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates","volume":"103","author":"Masters","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2307\/3583465","article-title":"Weight changes in clients on hormonal contraceptives in Zaria, Nigeria","volume":"9","author":"Sule","year":"2005","journal-title":"Afr. J. Reprod. Health"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1590\/S0104-42302006000100019","article-title":"Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil","volume":"52","author":"Yela","year":"2006","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0130","first-page":"686","article-title":"Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia","volume":"19","author":"Behnamfar","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0135","first-page":"421","article-title":"A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation","volume":"40","author":"Karimi-Zarchi","year":"2013","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13625187.2014.951433","article-title":"Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use","volume":"20","author":"Modesto","year":"2015","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.ygyno.2015.12.010_bb0145","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00404-012-2224-7","article-title":"Body weight changes after the diagnosis of endometrial cancer and their influences on disease-related prognosis","volume":"285","author":"El-Safadi","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.007","article-title":"Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer","volume":"133","author":"Gonthier","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2014.02.020","article-title":"Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin","volume":"133","author":"Simpson","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cam4.353","article-title":"Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer","volume":"4","author":"Schuler","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-9966-33-41","article-title":"Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma","volume":"33","author":"Shao","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0170","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose\u2013response study by the Gynecologic Oncology Group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.010_bb0175","series-title":"ClinicalTrials.gov [Internet]","article-title":"Metformin with the levonorgestrel-releasing intrauterine device for the treatment of complex atypical hyperplasia (CAH) and endometrial cancer (EC) in non-surgical patients","author":"UNC Lineberger Comprehensive Cancer Center","year":"2000"},{"issue":"11","key":"10.1016\/j.ygyno.2015.12.010_bb0180","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum. Reprod."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815302146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815302146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T18:20:07Z","timestamp":1537122007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815302146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0090825815302146"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}